GFAP and Alzheimer disease: Western blots of AD(3,3) and AD(4,4) samples confirmed significant enrichment of hyperphosphorylated GFAP (hP-GFAP) in AD tissue relative to AMC (Figure 1c); each genotype group differed from AMC(3,3) control samples at p < 0.0001.